Latest Breaking News On - Bioscience united states - Page 1 : comparemela.com

Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization

/PRNewswire/ South Korea s biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry.

South koreaUnited statesPuerto ricoSoult ukpyolsiRepublic ofSang giCholla buktoJoobin jungHyundai bioscienceSouth americaSoutheast asiaBioscience united statesGlobal marketing managerHealth care amp hospitalsInfection controlMedical pharmaceuticals

Hyundai Bioscience, US NIH to co-develop broad-spectrum antiviral drug

Hyundai Bioscience said Sunday it will develop a broad-spectrum antiviral drug with the U.S. National Institutes of Health (NIH), a federal agency for conducting and supporting medical research.

South koreaUs national institutes of healthAntiviral program for pandemicsNational institute of allergyPrevention agencyBioscience united statesHyundai bioscienceNon clinical evaluation agreementNational instituteInfectious diseasesHyundai bioscience united statesAntiviral programKorea disease controlUs nihSouth koreaHe korea times

Hyundai Bioscience, U S NIH to Co-develop Broad-spectrum Antiviral Drug

Hyundai Bioscience, U S NIH to Co-develop Broad-spectrum Antiviral Drug
koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.

South koreaSoult ukpyolsiUs national institutes of healthAntiviral program for pandemicsHyundai bioscience coNational institute of allergyPrevention agencyKorea bizwireHyundai bioscienceBioscience united statesNon clinical evaluation agreementNational instituteInfectious diseasesHyundai bioscience united statesAntiviral programKorea disease control